Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei.
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei.
复制标题
以结构为指导发现对布氏锥虫具有有效活性的选择性甲硫氨酰-tRNA 合成酶抑制剂。
DOI:
10.1039/d0md00057d
复制
发表时间:
2020
影响因子:
4.1
通讯作者:
Buckner,Fre
中科院分区:
文献类型:
--
作者:
Zhang,Zhongsheng;Barros-Álvarez,Ximena;Gillespie,JRobert;Ranade,RanaeM;Huang,Wenlin;Shibata,Sayaka;Molasky,NoraMR;Faghih,Omeed;Mushtaq,Aisha;Choy,RobertKM;deHostos,Eugenio;Hol,WimGJ;Verlinde,ChristopheLMJ;Buckner,Fre
Based on crystal structures of Trypanosoma brucei methionyl-tRNA synthetase (TbMetRS) bound to inhibitors, we designed, synthesized, and evaluated two series of novel TbMetRS inhibitors targeting this parasite enzyme. One series has a 1,3-dihydro-imidazol-2-one containing linker, the other has a rigid fused aromatic ring in the linker. For both series of compounds, potent inhibition of parasite growth was achieved with EC50 < 10 nM and most compounds exhibited low general toxicity to mammalian cells with CC50s > 20 000 nM. Selectivity over human mitochondrial methionyl tRNA synthetase was also evaluated, using a cell-based mitochondrial protein synthesis assay, and selectivity in a range of 20–200-fold was achieved. The inhibitors exhibited poor permeability across the blood brain barrier, necessitating future efforts to optimize the compounds for use in late stage human African trypanosomiasis.